A Solid Group with Three Companies in one group
Auxesis Pharma Holding AB(publ)
Auxesis Pharma Holding AB (publ)Auxesis Pharma Holding AB is the parent company and owns the rights to patents in specific medical research areas. Auxesis Pharma Holding in turn owns two subsidiaries: Auxesis MedTech AB and Auxesis Animal Care AB. It is a publicly registered company, meaning it is a limited company whose articles of association include a provision that the company's shares must be registered in a securities register (read more on Bolagsverket). The company is a parent company and holds the rights to patents within specific medical research areas. Auxesis Pharma Holding AB (publ) focuses on the development of innovative pharmaceuticals for the treatment of localized pain and skin irritation, for both humans and animals.
Business Idea
Building on its own patents, Auxesis develops innovative pharmaceuticals that effectively relieve pain and skin irritation. The products are easy to use and accessible to both consumers and professional sectors. After years of research and thousands of tests, Auxesis, in collaboration with the research team at Karolinska Institutet in Stockholm, has achieved something unique: stabilizing acetylsalicylic acid (ASA) in liquid form. This stabilization, combined with other already approved pharmaceuticals, enables direct application to the skin.
Milestones and Future
In the summer of 2025, the company will celebrate 10 years. Since its inception, Auxesis has evolved from an initial idea through research and capitalization to preclinical testing and global PCT patent protection. The goal is to achieve approval for the groundbreaking product ASA.P® by 2026, followed by a public listing. Currently, Auxesis has two globally registered trademarks: ASA.P® and CoxyPet®.
Auxesis MedTech AB
Auxesis MedTech AB was founded in 2024 and is part of Auxesis Pharma Holding AB. Initially, Auxesis MedTech AB will manage prototype manufacturing and hold the license to produce and market our medical products in the Nordic region, as well as licenses for the rest of the world. To ensure the highest possible standards and efficiency, we are establishing our own state-of-the-art factory in Östersund, specifically designed for the production of our own products. By maintaining full control over the production process, we can guarantee a unique and customized product quality, as well as controlled deliveries.
Auxesis Animal Care AB
Auxesis Animal Care AB develops products for the animal care market, focusing on dogs, cats, and the livestock industry. There is a clear demand and market need among both pet owners and veterinarians for a product that effectively addresses pain on animals' skin. Therefore, in the next phase, we will direct our research and development towards the veterinary pharmaceutical category.
